Page 238 - Veterinary Laser Therapy in Small Animal Practice

224 Veterinary Laser Therapy in Small Animal Practice

301. Pertille, A., A.B. Macedo, and C.P. Oliveira. nexvet-canine-osteoarthritis-drug-meets-main-goal-in-
Evaluation of muscle regeneration in aged animals after study-idUSKCN0T523520151116 (accessed September
treatment with low-level laser therapy. Rev Bras Fisioter, 2018).
2012. 16(6): pp. 495–501. 317. Carmichael, S. Optimising efficacy and minimising
302. Leal Junior, E.C., et al. Effect of 830 nm low-level laser toxicity of NSAIDs. 2016. Proceedings of the 22nd
therapy applied before high-intensity exercises on skeletal FECAVA Eurocongress, Vienna, Austria. Available
muscle recovery in athletes. Lasers Med Sci, 2009. 24(6): at: http://www.fecava2016.org/programme (accessed
pp. 857–63. September 2018).
303. Felismino, A.S., et al. Effect of low-level laser therapy 318. Smith, G.K., et al. Lifelong diet restriction and
(808 nm) on markers of muscle damage: a randomized radiographic evidence of osteoarthritis of the hip joint in
double-blind placebo-controlled trial. Lasers Med Sci, dogs. J Am Vet Med Assoc, 2006. 229(5): pp. 690–3.
2014. 29(3): pp. 933–8. 319. Impellizeri, J.A., M.A. Tetrick, and P. Muir. Effect of
304. McPartland, J.M. Travell trigger points–molecular weight reduction on clinical signs of lameness in dogs with
and osteopathic perspectives. J Am Osteopath Assoc, 2004. hip osteoarthritis. J Am Vet Med Assoc, 2000. 216(7): pp.
104(6): pp. 244–9. 1089–91.
305. Cummings, M. and P. Baldry. Regional myofascial 320. Salinardi, B.J., et al. Matrix metalloproteinase and
pain: diagnosis and management. Best Pract Res Clin tissue inhibitor of metalloproteinase in serum and synovial
Rheumatol, 2007. 21(2): pp. 367–87. fluid of osteoarthritic dogs. Vet Comp Orthop Traumatol,
306. McPartland, J.M. and J.P. Goodridge. Counterstrain 2006. 19(1): pp. 49–55.
diagnostics and traditional osteopathic examination of the 321. Alam, M.R., et al. Biomarkers for identifying the
cervical spine compared. J Bodyw Mov Ther, 1997. 1(3): early phases of osteoarthritis secondary to medial patellar
pp. 173–8. luxation in dogs. J Vet Sci, 2011. 12(3): pp. 273–80.
307. Janssens, L.A. Trigger point therapy. Probl Vet Med, 322. Hurlbeck, C., et al. Evaluation of biomarkers for
1992. 4(1): pp. 117–24. osteoarthritis caused by fragmented medial coronoid
308. Janssens, L.A.A. Trigger points in 48 dogs with process in dogs. Res Vet Sci, 2014. 96(3): pp. 429–35.
myofascial pain syndromes. Vet Surg, 1991. 20(4): pp. 323. Volk, S.W., et al. Gelatinase activity in synovial
274–8. fluid and synovium obtained from healthy and
309. Uemoto, L., et al. Laser therapy and needling in osteoarthritic joints of dogs. Am J Vet Res, 2003. 64(10):
myofascial trigger point deactivation. J Oral Sci, 2013. pp. 1225–33.
55(2): pp. 175–81. 324. Hegemann, N., et al. Cytokine profile in canine
310. Gur, A., et al. Efficacy of 904 nm gallium arsenide immune-mediated polyarthritis and osteoarthritis. Vet
low level laser therapy in the management of chronic Comp Orthop Traumatol, 2005. 18(2): pp. 67–72.
myofascial pain in the neck: a double-blind and 325. Hegemann, N., et al. Synovial MMP-3 and TIMP-1
randomize-controlled trial. Lasers Surg Med, 2004. 35(3): levels and their correlation with cytokine expression in
pp. 229–35. canine rheumatoid arthritis. Vet Immunol Immunopathol,
311. Johnston, S.A. Osteoarthritis. Joint anatomy, 2003. 91(3–4): pp. 199–204.
physiology, and pathobiology. Vet Clin North Am Small 326. de Bakker, E., et al. Canine synovial fluid biomarkers
Anim Pract, 1997. 27(4): pp. 699–723. for early detection and monitoring of osteoarthritis. Vet
312. Rialland, P., et al. Clinical validity of outcome pain Rec, 2017. 180(13): pp. 328–29.
measures in naturally occurring canine osteoarthritis. 327. Pallotta, R.C., et al. Infrared (810-nm) low-level laser
BMC Vet Res, 2012. 8: p. 162. therapy on rat experimental knee inflammation. Lasers
313. Slingerland, L.I., et al. Cross-sectional study of the Med Sci, 2012. 27(1): pp. 71–8.
prevalence and clinical features of osteoarthritis in 100 328. Barretto, S.R., et al. Evaluation of anti-nociceptive
cats. Vet J, 2011. 187(3): pp. 304–9. and anti-inflammatory activity of low-level laser therapy
314. Lascelles, B.D., et al. Cross-sectional study of the on temporomandibular joint inflammation in rodents. J
prevalence of radiographic degenerative joint disease Photochem Photobiol B, 2013. 129: pp. 135–42.
in domesticated cats. Vet Surg, 2010. 39(5): pp. 329. Mantineo, M., J.P. Pinheiro, and A.M. Morgado.
535–44. Low-level laser therapy on skeletal muscle inflammation:
315. Schmidt, J. Even painkillers for dogs have serious evaluation of irradiation parameters. J Biomed Opt, 2014.
risks. USA Today, 2005, 4 November. 19(9): p. 98002.
316. Penumudi, A. Nexvet canine osteoarthritis 330. Aliodoust, M., et al. Evaluating the effect of low-
drug meets main goal in study. 2015. Available at: level laser therapy on healing of tenotomized Achilles
https://www.reuters.com/article/us-nexvet-study/ tendon in streptozotocin-induced diabetic rats by light

REDONDO PRINT (4-COL BLEED).indd 224 08/08/2019 09:51